首頁 > 市場調查報告書 > 製藥

藥物開發臨床實驗臨床開發

市場調查報告書

商品編碼

1677773

臨床試驗基礎設施區域市場分析：中東和北非

Clinical Trial Infrastructure Regional Analysis Market: Middle East and North Africa

出版日期: 2025年03月05日 | 出版商:

BCC Research | 英文 81 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

本報告研究了中東和北非的臨床試驗基礎設施市場，並提供了市場概況摘要、市場影響因素和市場機會分析、市場規模趨勢和預測、每個主要國家的詳細分析以及競爭格局。

全球臨床試驗市場概覽
中東和北非地區
中東和北非不斷發展的臨床試驗產業
基礎設施和資源：彌補新興市場的差距
患者招募潛力：患者群體多樣化，招募率高
經濟高效
法規環境：協調與在地化
政府支持和投資
地方政策的影響：鼓勵臨床研究
合作拓展本地網路
新興趨勢：關注精準醫療和罕見疾病
腫瘤學和罕見疾病的需求不斷成長
技術進步：臨床業務數位化
了解中東和北非的臨床試驗狀況

第3章市場動態

市場動態
市場促進因素
推動試驗可行性的法律規範
增加患者人數以加強招募和多樣性
透過技術進步提高業務效率
合作
個性化醫療試驗設計
市場挑戰
複雜的監管格局
患者招募和保留的局限性
基礎設施和場地容量不足
數位技術採用有限
關鍵治療領域的競爭
市場機會
監理改革加速核准速度
腫瘤學和罕見疾病的新焦點
透過公私合營加強研究能力
專注於精準醫學和基因組學

第4章市場區隔分析

細分市場
市場分析：依贊助商類型
市場分析：按階段
按服務類型進行的市場分析
按研究類型進行的市場分析
按治療領域分類的市場分析

第5章新興市場

埃及
概述
臨床試驗狀況分析
觀察
密件抄送建議
沙烏地阿拉伯（KSA）
概述
臨床試驗狀況分析
觀察
密件抄送建議
黎巴嫩
概述
臨床試驗狀況分析
觀察
密件抄送建議
UAE
概述
臨床試驗狀況分析
觀察
密件抄送建議
伊朗
概述
臨床試驗狀況分析
觀察
密件抄送建議

第6章俄烏戰爭影響分析

概述
供應鏈中斷
監管挑戰
患者招募和保留
地緣政治風險

第7章競爭格局

概述
競爭格局
國際 CRO 和製藥公司
本地 CRO 和代理機構
學術研究所
臨床試驗產品和服務映射
中東和北非臨床試驗的最新趨勢
BCC的結語

第 8 章附錄

簡介目錄圖表

Product Code: HLC304A

This report provides an overview of the clinical trial infrastructure markets in the Middle East and North Africa (MENA) region. It includes a detailed examination of the market dynamics and an understanding of the MENA clinical trial landscape by study status, phase, type, results and sponsor type.

Report Scope

This report analyzes the Middle East and North Africa (MENA) clinical trial markets, using 2023 as a benchmark year, and offers projections for the forecast period from 2024 to 2029, with estimates of compound annual growth rates (CAGR). The report covers many aspects of the market, including clinical advances, economic factors and business considerations, and outlines the market forces impacting the industry and its phases, study types and therapeutic areas. The report segments the clinical trial market into services, solutions and supplies, and examines the regional dynamics influencing the market.

This report excluded Turkey and Israel from its scope because their clinical trial markets are significantly more advanced than other countries in the MENA region. Including these markets would have skewed the analysis and not accurately reflected the opportunities and challenges the rest of the region faces. This approach ensures a focused examination of MENA's emerging clinical trial landscape, which may be more relevant for companies seeking to expand into less mature markets.

Report Includes

Analysis of the Middle East and Northern Africa's (MENA) regional markets for clinical trial infrastructure
Analyses of the market trends, with revenue data for 2023, estimates for 2024, and projected CAGRs through 2029
Estimate of the current market size and revenue prospects, accompanied by a market share analysis by sponsor type, clinical trial phase, service type, study type, therapeutic area, and country
An understanding of the opportunities and progressions in clinical trial studies by some select countries in emerging MENA markets
Facts and figures pertaining to the current market dynamics, advancements in technology, regulations and prospects
Insights of the ripple effects of the Ukraine-Russia war on clinical trial operations, including supply chain disruptions, regulatory challenges, and patient recruitment and retention
Analysis of the industry structure, including stakeholders' market shares, clinical trial product/services mapping, and recent key developments

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Reasons for Doing this Study
Market Summary

Chapter 2 MENA Clinical Trial Industry Outlook

Global Clinical Trial Market Overview
MENA Share
Evolving MENA Clinical Trial Industry
Infrastructure and Resources: Bridging Gaps in Emerging Markets
Patient Recruitment Potential: Diverse Populations and High Recruitment Rates
Cost-Effectiveness
Regulatory Environment: Harmonization and Local Adaptations
Government Support and Investments
Impact of Regional Policies: Incentivizing Clinical Research
Collaborations Expand Regional Networks
Emerging Trends: Focus on Precision Medicine and Rare Diseases
Growing Demand in Oncology and Rare Diseases
Technological Advances: Digitalizing Clinical Operations
Understanding the MENA Clinical Trial Landscape

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Regulatory Frameworks Driving Trial Feasibility
Growing Patient Population Enhancing Recruitment and Diversity
Technological Advances Streamlining Operations
Collaborations
Personalized Medicine Shaping Trial Design
Market Challenges
Complex Regulatory Landscape
Limited Patient Recruitment and Retention
Insufficient Infrastructure and Site Capacity
Limited Adoption of Digital Technologies
Competition for Key Therapeutic Areas
Market Opportunities
Regulatory Reforms Enabling Faster Approvals
Emerging Focus on Oncology and Rare Diseases
Public-Private Partnerships Boosting Research Capacity
Focus on Precision Medicine and Genomics

Chapter 4 Market Segmentation Analysis

Segmentation Breakdown
Market Analysis, by Sponsor Type
Market Analysis, by Phase
Market Analysis, by Service Type
Market Analysis, by Study Type
Market Analysis, by Therapeutic Area

Chapter 5 Emerging Markets

Egypt
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
Kingdom of Saudi Arabia (KSA)
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
Lebanon
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
United Arab Emirates
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
Iran
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations

Chapter 6 Russia-Ukraine War Impact Analysis

Overview
Supply Chain Disruptions
Regulatory Challenges
Patient Recruitment and Retention
Geopolitical Risks

Chapter 7 Competitive Landscape

Overview
Competitive Landscape
International CROs and Pharmaceutical Companies
Local CROs and Institutions
Academic and Research Institutions
Mapping of Clinical Trial Product Services
Recent Developments in Clinical Trials in the MENA Region
Concluding Remarks from BCC

Chapter 8 Appendix

Methodology
Research Steps
Sources
Abbreviations

簡介目錄圖表

List of Tables

Summary Table : MENA Market for Clinical Trials, by Country, Through 2029
Table 1 : MENA Clinical Trial Analysis, by Study Status, Through 2024
Table 2 : Comparison of MENA Clinical Trial Regulations, Through 2024
Table 3 : Comparison of MENA Clinical Trial Regulations, Through 2024
Table 4 : MENA Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 5 : Regulatory Bodies for Conducting Clinical Trials in the MENA Region
Table 6 : Recent Technological Advances in the MENA Clinical Trial Market, 2023 and 2024
Table 7 : Recent Collaborations in the MENA Clinical Trial Market, 2024
Table 8 : Recent Developments in Clinical Trial Infrastructure in MENA, 2023 and 2024
Table 9 : Leading Causes of Death in MENA, by Country, 2021
Table 10 : Recent Developments in the MENA Region, 2023 and 2024
Table 11 : Recent Collaborations in the MENA Region, 2024
Table 12 : Leading MENA Countries for Clinical Trials, by Sponsor Type, Through 2024
Table 13 : MENA Market for Clinical Trials, by Sponsor Type, Through 2029
Table 14 : Leading MENA Countries for Clinical Trials, by Phase, Through 2024
Table 15 : MENA Market for Clinical Trials, by Phase, Through 2029
Table 16 : MENA Market for Clinical Trials, by Service Type, Through 2029
Table 17 : Leading MENA Countries for Clinical Trials, by Study Type, Through 2024
Table 18 : MENA Market for Clinical Trials, by Study Type, Through 2029
Table 19 : MENA Market for Clinical Trials, by Therapeutic Area, Through 2029
Table 20 : Egyptian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 21 : Companies and Research Institutes for Clinical Trials in Egypt
Table 22 : Egyptian Market for Clinical Trials, by Value, Through 2029
Table 23 : Saudi Arabian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 24 : Companies and Research Institutes for Clinical Trials in the KSA
Table 25 : Saudi Arabian Market for Clinical Trials, by Value, Through 2029
Table 26 : Lebanese Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 27 : Companies and Research Institutes for Clinical Trials in Lebanon
Table 28 : Lebanese Market for Clinical Trials, by Value, Through 2029
Table 29 : UAE Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 30 : Companies and Research Institutes for Clinical Trials in UAE
Table 31 : UAE Market for Clinical Trials, by Value, Through 2029
Table 32 : Iranian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 33 : Companies and Research Institutes for Clinical Trials in Iran
Table 34 : Iranian Market for Clinical Trials, by Value, Through 2029
Table 35 : MENA Clinical Trials Product/Services Mapping Analysis
Table 36 : Recent Developments in the MENA Clinical Trial Market, 2020-2024
Table 37 : Information Sources in this Report
Table 38 : Abbreviations Used in this Report

List of Figures

Summary Figure : MENA Market for Clinical Trials, by Country, 2023-2029
Figure 1 : Global Market for Clinical Trials, by Value, 2023-2029
Figure 2 : Share of the Global Clinical Trials Market Value, by Region, 2023
Figure 3 : Key Considerations for MENA Clinical Trials
Figure 4 : Market Dynamics of Clinical Trial Infrastructure in the MENA Region
Figure 5 : Share of Deaths, by Broad Cause, by Country, 2021
Figure 6 : Share of MENA Market for Clinical Trials, by Sponsor Type, 2023
Figure 7 : Share of MENA Market for Clinical Trials, by Phase, 2023
Figure 8 : Share of MENA Market for Clinical Trials, by Service Type, 2023
Figure 9 : Share of MENA Market for Clinical Trials, by Study Type, 2023
Figure 10 : Share of MENA Market for Clinical Trials, by Therapeutic Area, 2023
Figure 11 : Egyptian Market for Clinical Trials, by Value, 2023-2029
Figure 12 : BCC Recommendations for the Egyptian Market for Clinical Trials
Figure 13 : Saudi Arabian Market for Clinical Trials, by Value, 2023-2029
Figure 14 : BCC Recommendations for Saudi Arabian Clinical Trials
Figure 15 : Lebanese Market for Clinical Trials, by Value, 2023-2029
Figure 16 : BCC Recommendations for Lebanese Clinical Trials
Figure 17 : UAE Market for Clinical Trials, by Value, 2023-2029
Figure 18 : BCC Recommendations for the UAE Clinical Trials
Figure 19 : Iranian Market for Clinical Trials, by Value, 2023-2029
Figure 20 : BCC Recommendations for the Iranian Clinical Trials
Figure 21 : Share of MENA Market for Clinical Trials, by Stakeholder, 2024
Figure 22 : Recommendations for Companies Looking to Enter the MENA Clinical Trial Market
Figure 23 : Methodology Used in the MENA Clinical Trial Market